Markets

Karyopharm Therapeutics Inc. reports lower fourth quarter loss and decreased revenue

by MarketNewsData

From Nasdaq, Inc.: 2025-02-19 19:55:10

Karyopharm Therapeutics Inc. reported a loss of $30 million in the fourth quarter, compared to a loss of $41 million the previous year. Earnings per share were -$0.24, improved from -$0.36 last year. Revenue dropped 9.1% to $30 million from $33 million in the same period. The company’s GAAP earnings show a decrease in loss and revenue compared to the previous year.



Read more at Nasdaq, Inc.: Karyopharm Therapeutics Inc. Q4 Loss Decreases

You may also like